Telmitren ES Tablet 40/5 mg

Adult dose

Telmisartan: Recommended oral dose is 40 mg once daily for adults with essential hypertension. Depending on the patient, 20 mg once daily may be effective, and the dose can be increased up to 80 mg once daily if necessary. For the purpose of reducing the risk of cardiovascular disease, 80 mg once daily is recommended for adults. For patients with mild to moderate liver impairment, the dose should not exceed 40 mg once daily. Rosuvastatin Calcium: For adults with primary hypercholesterolemia and others, the initial dose should be 5 mg once daily.

This medication should not be used during pregnancy. It can cause serious harm to the fetus, especially in the early, mid, and late stages of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals who are allergic or hypersensitive to any of the ingredients in this medication should not take it. Women who might become pregnant should use appropriate contraception, and it should not be administered to individuals who are pregnant or breastfeeding. Patients with significantly impaired liver or kidney function or certain liver diseases should consult a physician before using this medication, as its use may be contraindicated depending on the condition. Patients with muscle-related disorders or a history of myalgia or muscle weakness should be cautious while taking this medication, and if muscle pains or weakness become severe, they should consult a healthcare provider immediately. Due to its blood pressure-lowering effect, elderly patients or those with very low blood pressure should be cautious as they may experience dizziness or fainting. Interactions may occur when taking this medication alongside other drugs, so individuals taking other medications should inform their doctor or pharmacist. Particularly, caution is required when combined with certain diuretics, potassium supplements, or other cardiovascular medications. During treatment with this medication, regular tests should be conducted to monitor liver function and blood tests, specifically checking for muscle damage; any abnormal symptoms should be reported to a healthcare provider immediately. In case of overdose, symptoms such as hypotension, dizziness, and worsening kidney function may occur, so the prescribed dosages must be strictly adhered to. Caution is recommended while driving or operating machinery as dizziness or drowsiness may occur. Safety and efficacy in children have not been established, so use is not recommended. This medication contains lactose, so individuals with lactose intolerance should consult a healthcare provider before use. During treatment with this medication, it is advisable to avoid or limit alcohol intake, and special caution is warranted for those with a history of liver disease while undergoing liver function tests.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blistering, peeling skin, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory distress with cough and fever, jaundice (yellowing of skin or eyes), generalized malaise, sudden and severe headache, lightning-like headache, seizures, confusion, visual disturbances, paralysis, and coma.

Mild side effects

• Dyspepsia
• oral dysesthesia
• musculoskeletal stiffness
• acne
• itching
• dizziness
• nasopharyngitis
• dysuria
• rhinitis
• discomfort in the oropharynx

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain storage temperatures between 1 degree and 30 degrees Celsius. This will ensure the medication's efficacy is safely preserved.

Appearance

Light yellow oval film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTPX3)]